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Introduction
The incidence and mortality due to colorectal 
cancer, the third most commonly diagnosed can-
cer in the United States, has been steadily declin-
ing over the past several decades due in large part 
to increased uptake of screening, particularly with 
colonoscopy [Edwards et  al. 2010; American 
Cancer Society, 2013]. Colonoscopy reduces 
colorectal cancer risk and mortality by allowing 
for the identification and removal of precancerous 
adenomas [Winawer et al. 1993].
Background
Adenomas are the premalignant lesions that pre-
cede the majority of colorectal cancers and, while 
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Abstract
Introduction: The quality of the bowel preparation directly influences colonoscopy 
effectiveness. Quality indicators are widely employed to monitor operator performance 
and to gauge colonoscopy effectiveness. Some have suggested that the enumeration of the 
mean number of adenomas per colonoscopy (MNA) may be a more useful measure of bowel 
preparation quality, but evidence of the utility of this metric is limited. The relationship 
between bowel preparation quality and MNA was assessed.
Methods: Records of adult patients, aged 50–74 years, who had undergone a screening 
colonoscopy in a 6 month period at a hospital-based endoscopy suite in New York City 
were examined. Excluded were those who were symptomatic or having a colonoscopy for 
surveillance. Patient and procedural characteristics and clinical findings were abstracted 
from the endoscopy database. Bowel preparation quality was recorded as excellent, good, fair 
and poor. Histology and size of polyps removed were gathered from pathology reports. MNA 
was calculated and incident rate ratios assessing the relationship between bowel preparation 
quality, MNA, and covariates was calculated using Poisson regression.
Results: A total of 2422 colonoscopies were identified; 815 (33.6%) were screening 
colonoscopies among average risk individuals, 50–74 years; 203 (24.9%) had ≥1 adenomas; 
and 666 (81.7%) had excellent/good preparation quality. Overall MNA was 0.34 [standard 
deviation (SD) 0.68] and MNA was greater among those >60 years [incident rate ratio (IRR) 
1.89, 95% confidence interval (CI) 1.48–2.42), males (IRR 1.60, 95%CI 1.26–2.04) and those with 
good bowel preparation (IRR 2.54, 95%CI 1.04–6.16). Among those with ≥1 adenomas, MNA 
was 1.48 (SD 1.05) for excellent and 1.00 (SD 0.00) for poor quality preparation (p = 0.55).
Conclusions: We found that MNA is sensitive to changes in bowel preparation with higher 
MNA among those with good bowel preparation compared with those with poor preparation. 
Our evidence suggests MNA was particularly sensitive when restricted to only those in whom 
adenomas were seen.
Keywords: bowel preparation quality, colonoscopy, colorectal cancer screening
Correspondence to: 
Grace Clarke Hillyer, EdD, 
MPH  
Associate Research 
Scientist, Department of 
Epidemiology, Mailman 
School of Public Health, 
Columbia University, 722 
W. 168th Street, New York, 
NY 10032, USA. 
gah28@columbia.edu
Benjamin Lebwohl 
Department of Epidemiology, 
Mailman School of Public 
Health, Columbia University, 
New York, NY, USA  
Division of Liver and Digestive 
Diseases, College of Physicians 
and Surgeons, Columbia 
University, New York, NY, USA
Richard M. Rosenberg  
Edwin Hernandez  
Division of Liver and 
Digestive Diseases, College 
of Physicians and Surgeons, 
Columbia University, New 
York, NY, USA
Alfred I. Neugut 
Department of 
Epidemiology, Mailman 
School of Public Health, 
Columbia University, New 
York, NY, USA  
Division of Hematology 
and Oncology, College of 
Physicians and Surgeons, 
Columbia University, New 
York, NY, USA  
Herbert Irving 
Comprehensive Cancer 
Center, Columbia University, 
New York, NY, USA
Randi Wolf  
Teachers College, Columbia 
University, New York, NY, USA
Corey H. Basch 
Department of Public 
Health, William Paterson 
University, Wayne, NJ, USA
Jennie Mata  
Division of Hematology 
and Oncology, College of 
Physicians and Surgeons, 
Columbia University, New 
York, NY, USA
Douglas A. Corley  
Kaiser Permanente 
Division of Research, 
Oakland CA, USA
Steven Shea  
Department of Medicine, 
College of Physicians 
and Surgeons, Columbia 
University, New York, NY, USA 
Department of 
Epidemiology, Mailman 
School of Public Health, 
Columbia University, New 
York, NY, USA
Charles E. Basch  
Herbert Irving Comprehensive 
Cancer Center, Columbia 
University, New York, NY, USA  
Teachers College, Columbia 
University, New York, NY, 
USA
540222 TAG0010.1177/1756283X14540222Therapeutic Advances in GastroenterologyGC Hillyer, B Lebwohl
research-article2014
Original Research
TAG540222.indd   1 13/06/2014   4:42:57 PM
 at COLUMBIA UNIV on June 20, 2014tag.sagepub.comDownloaded from 
Therapeutic Advances in Gastroenterology 
2 http://tag.sagepub.com
every adenoma has the capacity to become can-
cer, few actually do [Risio, 2010]. Nonetheless, 
any adenoma detected, easily recognizable by 
their size, architectural growth, type, grade and 
dysplasia [Risio, 2010] is regarded as a potential 
colorectal cancer threat and removed during colo-
noscopy. The most consistent of predictors of the 
prevalence of adenomas are older age and male 
gender [Rex, 1995; Imperiale et  al. 2000; 
Lieberman et al. 2000; Rex et al. 2002; Heitman 
et  al. 2009; Corley et  al. 2013], but the risk of 
adenomas is also increased among those with a 
personal history of cigarette smoking [Anderson 
et al. 2003; Reid et al. 2003] and a family history 
of colorectal cancer [Rex et al. 1993; Lynch et al. 
2003].
The endoscopist’s ability to visualize the colonic 
mucosa is critically important to the effectiveness 
of colonoscopy. Operator skill, experience and 
diligence in examining the full length of the colon, 
as well as the use of imaging adjuncts enhances 
visualization, but equally essential is the quality of 
the bowel preparation [Rex et  al. 2006]. Bowel 
preparation quality is, in turn, contingent upon 
various patient-related factors (age and gender 
for example), the tolerability and efficacy of the 
purgative regimen, and aspects the procedure 
itself such as having a morning versus afternoon 
procedure [Ness et al. 2001; Sanaka et al. 2006; 
Wexner et al. 2006; Belsey et al. 2007; Siddiqui 
et al. 2009]. That there is an association between 
bowel preparation quality and the detection of 
adenomas exists has been noted by others. 
Froehlich and colleagues in the European Panel 
of Appropriateness of Gastrointestinal Endoscopy 
European Multicenter Study examined the 
impact of cleansing quality on colonoscopy diag-
nostic yield for more than 5800 colonoscopies 
and found that polyps were more likely detected 
among those with high-quality cleansing com-
pared with low-quality [odds ratio (OR 1.46, 95% 
confidence interval (CI) 1.11–1.93) [Froehlich 
et al. 2005]. In a review of 113,272 colonoscopies 
in the Clinical Outcomes Research Initiative 
(CORI) database, Harewood and colleagues 
demonstrated that adequate preparation (excel-
lent or good) was associated with the detection of 
colonic lesions (OR 1.21, 95% CI 1.16–1.25) 
compared with inadequate preparation (fair or 
poor) [Harewood et al. 2003].
Quality indicators are widely employed to moni-
tor operator performance and gauge colonoscopy 
effectiveness. Typically they include assessing 
cecal intubation using photodocumentation of 
landmarks during screening procedures among 
healthy persons (target 95%); individual 
endoscopist adenoma detection rate (ADR) 
≥25% in men and ≥15% in women aged 50 years 
and older; and when ADR is low, assessment of 
mean withdrawal time where optimal withdrawal 
time is 6 minutes or more [Rex et al. 2006]. Of 
these, ADR is considered the priority indicator 
and is the most widely used of the quality indica-
tors as it focuses on the primary reason for per-
forming screening colonoscopy – detection and 
removal of precancerous lesions. Derived by 
dividing the number of patients in whom any ade-
noma has been detected by the total number of 
colonoscopies performed, ADR is a binary meas-
ure (0 versus ≥1 adenomas) that provides no infor-
mation on total adenomas removed. However, 
some have suggested that enumeration of overall 
number of adenomas per colonoscopy [Wang 
et  al. 2011; Lee et  al. 2012; Rembacken et  al. 
2012; Denis et  al. 2014], calculated by dividing 
the total number of adenomas detected by the 
total number of colonoscopies performed, may be 
a more useful measure of adenoma detection 
[Rex et al. 2006; Wang et al. 2011; Lee et al. 2012; 
Rembacken et  al. 2012; Kahi et  al. 2014]. 
Evidence regarding the utility of this metric is 
limited. Only recently has the mean number of 
adenomas (MNA) per colonoscopy, overall and 
per positive procedure, been used to assess colo-
noscopy quality [Lee et  al. 2012, 2013, Denis 
et al. 2014]. In this study we sought to evaluate 
the relationship between MNA and bowel prepa-
ration quality among persons undergoing screen-
ing colonoscopy at a large, tertiary care center in 
New York City.
Materials and methods
The records of outpatients aged 50–74 years who 
had undergone a colonoscopy in a 6-month 
period between 1 September 2012 and 28 
February 2013 at Columbia University Medical 
Center were extracted from the electronic endos-
copy database. Those with a procedural indica-
tion of screening colonoscopy were selected for 
analysis. Indications such as family history of 
colorectal cancer or polyps in first degree 
relative(s), first degree relative(s) before the age of 
60 years, multiple second degree relatives, and 
distant relatives were also included (see 
Appendix). Excluded were indications of abdomi-
nal pain/distress, abnormal computerized tomog-
raphy (CT) or positron emission tomography 
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(PET) scan of the abdomen, anemia, celiac dis-
ease, change in bowel habits, Crohn’s disease, 
chronic constipation or diarrhea, diverticulitis, 
hematochezia, heme positive stool, hereditary 
nonpolyposis colorectal cancer, high risk surveil-
lance, presurgical assessment for organ trans-
plant, personal history of colorectal cancer or 
polyps, and rectal bleeding. Records of the pathol-
ogy department were subsequently queried to 
assemble a list of patients using the above criteria 
whose pathology reports included a diagnosis of 
benign neoplasm of the colon and/or benign neo-
plasm of the rectum. Comparison of the two lists 
ensured completeness of the data extraction and 
created a definitive roster of patients diagnosed 
with adenomas.
The following information was abstracted from 
the endoscopy database: age; gender; examination 
date; time of procedure (morning prior to 12:00 
versus afternoon); procedural difficulty (not diffi-
cult, somewhat difficult, moderately difficult, or 
difficult); patient’s tolerance of the procedure 
(tolerated well versus not tolerated well); number 
of adenomas; and size (<10 mm versus ≥10 mm). 
Based on the American Society for Gastrointestinal 
Endoscopy (ASGE) and American College of 
Gastroenterology (ACG) Taskforce on Quality in 
Endoscopy recommendations [Rex et  al. 2006], 
bowel preparation quality was assessed as excel-
lent if no or minimal amounts of solid stool were 
present and suctioning was required for only 
small amounts of clear liquid; good if no or mini-
mal amounts of solid stool were present and suc-
tioning was required for large amounts of clear 
liquid; fair if semisolid debris was present that was 
difficult in removing; and poor if solid or semi-
solid debris was present that could not be cleared 
sufficiently.
In 10.3% (21/203) of patients who had adenomas 
detected, multiple polyps submitted in one fixa-
tive jar for histological review were counted con-
servatively as one adenoma [Lebwohl et al. 2012]. 
From the pathology reports, polyps histologically 
classified as adenomas were tabulated and adeno-
mas of the tubulovillous or villous type, tissue 
with high-grade dysplasia, or adenomas greater 
than or equal to 10 mm in size were classified as 
advanced adenomas. All colonoscopy and pathol-
ogy reports were manually reviewed by a single 
auditor (G.C.H.). A random 20% sample was re-
audited by two gastroenterologists (B.L. and 
R.M.R.) and Cohen’s Kappa statistic was calcu-
lated to demonstrate inter-rater reliability of the 
recording of bowel preparation quality (K = 0.93) 
and number of adenomas detected (K = 0.83). 
Cecal intubation rate was 96.9%. This study was 
reviewed and approved by the medical center’s 
institutional review board.
Data analysis
The MNA per colonoscopy was defined as the 
total number of adenomas detected divided by 
the number of colonoscopies performed. We 
examined the relationship between patient demo-
graphic and procedure-related characteristics and 
MNA using Chi square and Student’s t tests. The 
overall MNA was calculated in addition to MNA 
stratified by age, gender and preparation quality 
using analysis of variance (ANOVA). A similar 
subanalysis among only those in whom ≥1 adeno-
mas were detected was also performed. Using 
Poisson regression, we calculated incident rate 
ratios (IRR) to assess the relationship between 
age, gender and bowel preparation quality, and 
MNA. Lastly, we performed a secondary analysis 
to compare ADR, determined by dividing the 
number of patients with at least one adenoma by 
the total number of colonoscopies, and MNA. All 
analyses were conducted using IBM SPSS ver-
sion 21.
Results
A total of 2442 colonoscopies were performed 
during the 6-month period. Of these, 232 (9.6%) 
were inpatients, 606 (25.0%) were less than 50 or 
greater than 74 years of age, and 769 (31.7%) 
were for indications other than screening (refer to 
the Appendix for a complete listing of indica-
tions). The remaining 815 screening colonosco-
pies were performed by 45 providers (38 attending 
gastroenterologists and seven fellows). The major-
ity of patients were younger than 60 years (52.5%) 
and female (57.4%) (Table 1). Most procedures 
were performed in the morning before 12:00 
(59.1%), had ‘good’ bowel preparation quality 
(65.9%), and the suite-wide cecal intubation rate 
was 96.9%. Of these screening colonoscopies, 
203 (24.9%) patients had one or more adenomas 
detected.
Of patients in whom adenomas were detected, 
73.9% had only a single adenoma (Table 2). The 
majority of the adenomas detected were of the 
adenomatous/tubular type (88.7%) and were 
nonadvanced (83.2%). The MNA overall was 
0.34 [standard deviation (SD) 0.68] (Table 3). 
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Table 1. Characteristics of outpatients (n = 815) by number of adenomas detected who had undergone screening colonoscopy 








 N % N % N %  
Age 0.001
 ≤60 428 52.5 341 79.7 87 20.3  
 >60 387 47.5 270 69.8 117 30.2  
Gender 0.005
 Female 468 57.4 368 78.6 100 21.4  
 Male 347 42.6 243 70.0 104 30.0  
Time of colonoscopy 0.30
 AM 482 59.1 355 73.7 127 26.3  
 PM 333 40.9 256 76.9 77 23.1  
Preparation quality* 0.23
 Poor 38 4.7 33 86.8 5 13.2  
 Fair 94 11.5 70 74.5 24 25.5  
 Good 537 65.9 394 73.4 143 26.6  
 Excellent 129 15.8 101 78.3 28 21.7  
Difficulty$ 0.77
 Not difficult 706 87.6 527 74.6 179 25.4  
 Difficult 100 12.4 76 76.0 24 24.0  
Tolerance‡ 0.84
 Well tolerated 777 98.8 581 74.8 196 77.8  
 Not well tolerated 9 1.1 7 25.2 2 22.2  
*Excludes those with preparation quality not noted (n = 17). $Excludes those with difficulty not noted (n = 9). ‡Excludes those with tolerance not 
noted (n = 29).
For patients >60 years of age, the MNA was 
nearly double that found in younger patients 
[0.44 (SD 0.82) versus 0.24 (SD 0.52), p < 0.001] 
and by gender; the MNA for males was signifi-
cantly greater than that of females [0.43 (SD 
0.80) versus 0.26 (SD 0.57), p <0.001]. The MNA 
among those with poor quality bowel preparation 
was 0.13 compared with 0.31, 0.34 and 0.36 for 
those with excellent, good or fair preparations, 
respectively (Table 3) (p = 0.25).
In our subanalysis among only patients who had 
one or more adenomas detected, a linear associa-
tion between MNA and age was observed with 
1.11 (SD 0.37) adenomas detected in the young-
est age group (50–55 years) rising to 1.62 (SD 
0.94) for the 71–75 year-old group (p = 0.019) 
(Figure 1). MNA was highest among procedures 
with excellent quality preparations [1.48 (SD 
1.05)], was lower but equivalent for good and fair 
preparations [1.34 (SD 0.68) and 1.33 (SD 0.48), 
respectively], and still lower for poor preparation 
quality [1.00 (SD 0.00), p = 0.55]. When examin-
ing the relationship between bowel preparation 
quality and mean number of proximal adenomas 
[excellent: 1.20 (SD 0.63); good: 1.26 (SD 0.55); 
fair: 1.28 (SD 0.47); poor: 1.00 (SD 0.00), p = 
0.78], and between preparation quality and mean 
number of distal adenomas [excellent: 1.00 (SD 
0.00); good: 1.13 (SD 0.43)]; fair: 1.14 ([SD 
0.38); poor: n = 0, p = 0.61], no trend was 
observed. Secondary analysis showed the ADR 
was higher in older patients (30.2% 60 years or 
older versus 20.3% younger than 60 years, p = 
0.001) and male patients (30.0% versus females 
21.4%, p = 0.005). The overall ADR was 25.0%; 
the ADR for males was 28.8% and 22.2% for 
females. ADR increased with age with 17.5% for 
50–55 year-olds and 31.9% for 71–75 year-olds 
(p = 0.007). Stratified by level of bowel prepara-
tion quality, the ADR was 21.7% for excellent 
preparation, 26.6% for good, 25.5% for fair and 
13.1% for poor preparations. In the regression 
analysis, adjusted for age and gender, there was 
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Table 2. Adenoma characteristics among outpatients (n = 203) in whom adenomas were detected with 
screening colonoscopy between 1 September 2012 and 28 February 2013.
n %
Number of adenomas  
 1 150 73.9
 2 41 20.1
 3 9 4.4
 4 1 0.5
 5 1 0.5
 6 1 0.5
Type$  
 Adenomatous/tubular 243 88.7
 Serrated 13 4.7
 Tubulovillous 15 5.5
 Villous 3 1.1
Advanced adenoma$,‡  
 Yes 37 13.5
 No 237 86.5
Size of adenoma$  
 ≤10 mm 241 87.9
 >10 mm 28 10.2
 Unknown 5 1.8
$A total of 274 adenomas were detected among 203 patients. ‡Includes villous and tubulovillous adenomas, adenomas 
with high grade dysplasia, and adenomas ≥10 mm in size.
Table 3. Mean number of adenomas per colonoscopy and Poisson regression analysis by select patient characteristics among 
outpatients (n = 815) who had undergone screening colonoscopy between 1 September 2012 and 28 February 2013.
Number of 
patients
Mean number  
of adenomas
SD p value IRR 95% CI
Mean number of adenomas 815 0.34 0.68 – – –
Age <0.001  
 ≤60 428 0.24 0.52 1.00 –
 >60 387 0.44 0.82 1.89 1.48-2.42
Gender <0.001  
 Female 468 0.26 0.57 1.00 –
 Male 347 0.43 0.80 1.60 1.26-2.04
Preparation quality*  0.25  
 Poor 38 0.13 0.34 1.00 –
 Fair 94 0.34 0.63 2.31 0.90–5.93
 Good 537 0.36 0.69 2.54 1.04-6.16
 Excellent 129 0.31 0.77 2.31 0.91–5.85
*Excludes those with preparation quality not noted (n = 17). Note: Bolded numbers represent statistically significant associations.
CI, confidence interval; IRR, incident rate ratio.
no statistically significant association between 
ADR and bowel preparation quality.
Discussion
Our findings demonstrate that the MNA is sig-
nificantly greater for those with ‘good’ bowel 
preparation compared with those with ‘poor’ 
preparation. We also found that increasing age 
(>60 years old) and male gender were associated 
with greater numbers of per patient adenomas, 
which coincides with reports of higher adenoma 
detection noted in the literature [Rex, 1995; 
Imperiale et al. 2000; Lieberman et al. 2000; Rex 
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et  al. 2002; Heitman et  al. 2009; Corley et  al. 
2013], among older individuals (>60 years) and 
for males. Our results suggest that the MNA may 
be sensitive to fine gradations in preparation qual-
ity, particularly among those in whom adenomas 
were seen, and may prove to be a useful measure 
of the effectiveness of colonoscopy as proposed by 
others [Rex et  al. 2006; Wang et  al. 2011; Lee 
et al. 2012; Rembacken et al. 2012].
Several studies have utilized MNA as an indicator 
of the quality of colonoscopy and support the effi-
cacy of MNA as a sensitive metric to evaluate 
bowel preparation quality, but these studies have 
been conducted almost exclusively in the context 
of stool-based colorectal cancer screening pro-
grams [Lee et al. 2012, 2013; Denis et al. 2014]. 
Since the risk of adenoma detection on colonos-
copy following a positive fecal-based colorectal 
cancer screening test is substantially greater [UK 
Colorectal Cancer Screening Pilot Group, 2004] 
than that associated with a screening colonoscopy 
of an average risk individual, these studies gener-
ally yielded a higher MNA than those found in 
our study, overall and among only those with ade-
nomas detected. Lee and colleagues in a study 
measuring the quality of colonoscopy following a 
positive fecal occult blood test, reported the mean 
number of adenomas per procedure (MAP) was 
0.91 overall and the mean number of adenomas 
per positive procedure (MAP+) was 1.94 com-
pared with our findings of 0.34 and 1.34, 
respectively [Lee et  al. 2012]. Similarly, Denis 
and colleagues [Denis et al. 2014] used the MNA 
to establish benchmark rates for colonoscopy 
quality in a French stool-based colorectal cancer 
screening program. The range of MNA per colo-
noscopy varied widely (between 0.36 and 0.98) in 
this study which the authors attributed to interop-
erator differences, an observation supported by 
Wang and colleagues [Wang et  al. 2011] who 
found that adenomas under the curve (AUC) var-
ied based on the setting of the endoscopic prac-
tice (academic versus community-based) with 
AUC of 1.94 in academic settings compared 
with 1.65 among community-based practices 
(p < 0.001). Only one study utilized MNA to eval-
uate a specific colonoscopy procedural aspect as 
we did. In this study, MAP was used to demon-
strate the impact of increased colonoscopy with-
drawal time (CWT) and found that MAP 
increased from 0.77 to 0.94 as CWT increased 
from 7 to 11 minutes [Lee et al. 2013].
We found that, after adjusting for age and gender, 
ADR was not associated with level of bowel prep-
aration quality. Results from other studies regard-
ing this association vary. For example, the 
relationship between ADR and bowel preparation 
quality was examined in the UK Flexible 
Sigmoidoscopy Screening Trial in 2006. In this 
study, ADR was higher in flexible sigmoidoscopy 
examinations with excellent or good bowel 





















Male Female 50-55 56-60 61-65 66-70 71-75 Excellent Good Fair Poor
Gender Age Preparaon Quality
p = 0.55p = 0.057 p = 0.019
Figure 1. Mean number of adenomas (n = 276) by select patient characteristics among only patients in whom 
adenomas were detected (n = 203).
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[Thomas-Gibson et al. 2006]. Another study, also 
conducted in the UK, evaluated the impact of 
poor bowel preparation on colonoscopy quality 
indicators including polyp detection rate (no dis-
tinction between neoplastic and non-neoplastic 
polyps) [Butt et al. 2012]. For good, satisfactory 
and poor bowel preparation, the polyp detection 
rate was 20%, 20%, and 16%, respectively, com-
pared with our ADR findings of 26.6%, 25.5% 
and 13.1% for good, fair and poor quality, respec-
tively, demonstrating that ADR appears to be 
diminished by a poor preparation, but does not 
vary significantly among preparations deemed 
superior to the lowest quality.
This study has several limitations. This study was 
conducted at a single site, thus limiting the gener-
alizability of our findings to other sites and popu-
lation groups. Our sample size was relatively small 
with only 38 patients having poor bowel prepara-
tion, which may have limited our ability to detect 
significant associations between MNA and excel-
lent and fair bowel preparation. Our finding that 
only good preparation was associated with higher 
MNA likely reflects that large number of patients 
with good preparation compared with those with 
better or worse preparation quality. Intra-observer 
agreement in rating the bowel preparation quality 
was not assessed, which may have resulted in mis-
classification bias. The fact that MNA tends to 
improve among the highest preparation quality 
rating suggests that these gradations of quality 
reflect actual differences, rather than varying sub-
jective impressions of bowel cleanliness. We did 
not evaluate the impact of gastrointestinal (GI) 
fellows performing procedures on a subset of our 
cohort, which may have resulted in higher ade-
noma detection among select patients [Rogart 
et  al. 2008]. Non-intubation of the cecum is a 
confounder of the relationship between bowel 
preparation quality and MNA, as failure to reach 
the cecum is associated with both the exposure 
and the outcome. In our study, the cecum was not 
intubated in only 25 patients (3%). Due to the 
small number in whom the cecum was not intu-
bated, it is likely that nonintubation had little 
effect upon our results. This study was also lim-
ited in that information regarding the type of pur-
gative prescribed was not available, which may 
have provided additional insight to the relation-
ship between bowel preparation quality and 
MNA. Lastly, we conservatively counted multiple 
adenomas submitted in one fixative jar as a single 
adenoma. This practice may have resulted in an 
underestimation of MNA. Strengths of this study 
include a large sample size and that all adenoma 
results were histologically confirmed.
To date, no other study has evaluated whether 
this metric, MNA, is affected by bowel prepara-
tion quality. Future studies should test this 
hypothesis among larger cohorts of gastroenter-
ologists in which the determination of bowel 
preparation has been standardized [Lai et  al. 
2009], examine the mean number of right-sided 
adenomas, evaluate mean number of flat/serrated 
adenomas and determine the influence of bowel 
preparation strategies upon MNA. If confirmed, 
our findings may demonstrate that the mean ade-
noma count per colonoscopy is an important 
quality assessment outcome and a potentially use-
ful outcome when testing interventions to improve 
preparation quality.
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- Colon cancer screening, increased risk
-  Family history of colorectal cancer or colon polyps in 
first degree relative, multiple first degree relatives, 
multiple second degree relatives
-  Family history of cancer other than colorectal cancer
-  Personal history of malignant neoplasm other than 
colorectal cancer
- Screening for colon cancer
-  Screening for malignant neoplasm in colon or rectum
- Screening in patient at increased risk
- Abdominal pain, distress, mass or lump
-  Abnormal computerized tomography (CT), magnetic 










- Follow up of other conditions
- Hematochezia
- Heme positive stool
- High risk colorectal cancer surveillance
- History of malignant neoplasm of colon or rectum
- Hereditary nonpolyposis colorectal cancer (HNPCC)
- Inflammatory bowel disease
- Personal history of adenomatous polyps
- Pre-operative assessment
- Pre-organ transplant evaluation
- Surveillance
- Therapy of adenomatous polyps in rectum or colon
- Weight loss
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